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Summary
Otospondylomegaepiphyseal dysplasia (OSMED) is an
autosomal recessive skeletal dysplasia accompanied by
severe hearing loss. The phenotype overlaps that of the
autosomal dominant disorders—Stickler and Marshall
syndromes—but can be distinguished by disproportion-
ately short limbs, severe hearing loss, and lack of ocular
involvement. In one family with OSMED, a homozygous
GlyrArg substitution has been described in COL11A2,
which codes for the a2 chain of type XI collagen. We
report seven further families with OSMED. All affected
individuals had a remarkably similar phenotype: pro-
found sensorineural hearing loss, skeletal dysplasia with
limb shortening and large epiphyses, cleft palate, an ex-
tremely flat face, hypoplasia of the mandible, a short
nose with anteverted nares, and a flat nasal bridge. We
screened affected individuals for mutations in COL11A2
and found different mutations in each family. Individuals
from four families, including three with consanguineous
parents, were homozygous for mutations. Individuals
from three other families, in whom parents were non-
consanguineous, were compound heterozygous. Of the
10 identified mutations, 9 are predicted to cause pre-
mature termination of translation, and 1 is predicted to
cause an in-frame deletion. We conclude that the
OSMED phenotype is highly homogenous and results
from homozygosity or compound heterozygosity for
COL11A2 mutations, most of which are predicted to
cause complete absence of a2(XI) chains.
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Introduction
Otospondylomegaepiphyseal dysplasia (OSMED [MIM
215150]) is characterized by sensorineural hearing loss,
enlarged epiphyses, disproportionate shortness of the
limbs, and abnormalities in vertebral bodies. Patients
have typical facial features, including mid-face hypopla-
sia with a short upturned nose and depressed nasal
bridge. Cleft palate and a small mandible are also com-
mon findings (Insley and Astley 1974; Giedion et al.
1982; Ka¨a¨ria¨inen et al. 1993; Pihlajamaa et al. 1998;
Spranger 1998).
Type XI collagen is a heterotrimer composed of three
different a chains, a1(XI), a2(XI), and a3(XI) (Brewton
and Mayne 1994). The a3(XI) chain is a more exten-
sively posttranslationally modified product of the
COL2A1 gene, which codes for the a1 chain of type II
collagen (Eyre and Wu 1987). Type XI collagen is there-
fore encoded by three distinct genes, COL11A1,
COL11A2, and COL2A1 (Ala-Kokko et al. 1995; Vuo-
risto et al. 1995; Annunen et al. 1999). It is a quanti-
tatively minor fibrillar collagen expressed in hyaline car-
tilage, the vitreous body of the eye, and the intervertebral
disk together with the major cartilage collagen, type II
collagen. Type XI collagen interacts with type II collagen
fibrils and has been shown to play a role in regulating
fibril diameter (Linsenmayer et al. 1993; Cremer et al.
1998).
Because of the close structural and functional relation
between the collagen types XI and II, mutations in the
genes coding for them result in partially overlapping
phenotypes. Type II collagen mutations have been found
to cause a variety of cartilage disorders ranging from
lethal to mild conditions such as primary generalized
osteoarthritis (Ala-Kokko et al. 1990; Spranger et al.
1994; Horton 1996). Identification of COL2A1 pre-
mature translation termination codons in one allele of
patients with Stickler syndrome (MIM 108300) indi-
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Table 1
Primary Clinical Features of OSMED Patients in Seven Families
CHARACTERISTIC
STATUS OF PATIENTa
A:II3 A:II4 B:II3 B:II4 C:II1 D:II2 E:II2 F:II1 G:II1 G:II2
Age (years) 3 1.5 7 3 6 3 25 20 10 10
Height (cm) 86 78 115 89 106 83 150 147 122 124
Disproportionately short limbs          
Facial features:
Cleft palate b b      c  
Micrognathia          
Midface hypoplasia          
Flat mala          
Flat nasal bridge          
Short nose          
Anteverted nares          
Long philtrum          
Hypertelorism          
Midfacial hemangioma          
Enlarged joints       d  e e
Limited flexion of metacarpophalangeal joints        
Pectus excavatum       
Vertebral body anomalies       f f  
Kyphosis          
Lumbar lordosis          
Sensorineural hearing loss (dB) 80 50–70 80–90 100 70 60–110 90 50–90 90–95 90–95
High myopia          
a Mental development was normal in all patients.
b Cleft of soft palate.
c Bifid uvula and submucosal palatal cleft.
d Joint pain/stiffness and osteochondrosis in knee joint.
e Joint pain/stiffness.
f Osteochondrosis-like changes.
cated that the disease was caused by functional hap-
loinsufficiency (Horton 1996; Williams et al. 1996; An-
nunen et al. 1999). Stickler syndrome and Marshall
syndrome (MIM 154780) have also been associatedwith
mutations in COL11A1 (Richards et al. 1996; Griffith
et al. 1998; Annunen et al. 1999). Interestingly, none of
these mutations cause premature termination of trans-
lation. Four mutations have been identified in the
COL11A2 gene. A Gly175rArg substitution was found
in a family with recessive OSMED (Vikkula et al. 1995;
van Steensel et al. 1997), whereas an individual with
Weissenbacher-Zweymu¨ller syndrome (MIM 277610)
was heterozygous for a Gly955rGlu substitution (Pihla-
jamaa et al. 1998). COL11A2 mutations have also been
found in two families with nonocular Stickler syndrome
(MIM 184840). These mutations constituted a 27-bp
deletion in exon 39 (Sirko-Osadsa et al. 1998) and a
splicing mutation of exon 60 resulting in a deletion of
18 amino acid residues (Vikkula et al. 1995).
In spite of partial overlap between the Stickler, Mar-
shall, Weissenbacher-Zweymu¨ller, and OSMED pheno-
types caused by mutations in the COL2A1, COL11A1,
and COL11A2 genes, the absence of eye involvement in
patients carrying COL11A2 mutations is worth noting.
This is best explained by the finding that the COL11A2
gene is not expressed in the vitreous body and that the
a2(V) chain replaces the a2(XI) chain in this tissue
(Mayne et al. 1993).
Herein we describe clinical and molecular findings in
seven families with OSMED. All affected family mem-
bers were found to be homozygous or compound het-
erozygous for COL11A2 mutations, indicating that this
disorder is caused by mutations of the COL11A2 gene.
Subjects and Methods
Subjects
Blood samples were obtained from seven unrelated
patients with OSMED and their family members (fig.
1). The families with OSMED originated from Turkey,
Morocco, the Netherlands, and northern Europe, and
are referred to by letters “A”–“G.” Family members
were physically evaluated and the affected individuals
also radiologically and by audiometry. Individuals A:I1,
A:I2, B:I1, C:I1, and C:I2 refused clinical examination.
Radiographs were obtained from the parents of two
families (D:I1, D:I2, and E:I2). Audiometry was done to
the parents of families B and D. Blood samples from five
healthy volunteers, were used as controls in themutation
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Table 2
Clinical Summary of Phenotypes of Parents
PARENT
(SEX)
HEIGHT
(CM)
PHYSICAL
EXAMINATION
FACIAL
FEATURES HEARING
RADIOGRAPHY
Joints Examined Findingsa
A:I1 (M) 172 Not done Normal Normalb
A:I2 (F) 161 Not done Normal Normalb
B:I1 (M) 185 Not done Normal Normalc
B:I2 (F) 158 Normal Dysmorphicd Normalc
C:I1 (M) 176 Not done Normal Normalb
C:I2 (F) 162 Not done Normal Normalb
D:I1 (M) 182 Normal Normal Deficiente Hips, knees, ankles, spine Normal hips, knees, ankles; spinef
D:I2 (F) 178 Normal Normal Normalc Hips, knees, ankles, spine Normal hips, knees, and ankles; anomalies
in spineg
E:I1 (M) 180 Normal Normal Normalb
E:I2 (F) 168 Normal Dysmorphich Normalb Hips, wrist, hand, knees, spine Normal hips, wrist, and knees; anomalies
in handi and spinej
F:I1 (M) 174 Not done Normal Normalb
F:I2 (F) 167 Not done Normalk Normalk
G:I1 (M) 175 Normal Normal Normalb
G:I2 (F) 155 Normal Dysmorphicl Normalb
a No parents complained of pain in the joints.
b Not tested.
c On the basis of audiogram.
d Slightly flat face.
e On the basis of audiogram (mild hearing loss—20 dB on the left side and 40 on the right side—considered to be work related).
f Slight thoracic kyphosis, mild degenerative changes, one slightly wedge-shaped flattened vertebra, spondylolysis, and grade 1 spondylolisthesis
at L5.
g Slight thoracic kyphosis, mild degenerative changes.
h High palate, crowded teeth, micrognathia, and narrow face.
i Narrowing of distal interphalangeal joint space, irregular joint surfaces, a few minor cysts, and some chondrocalsinosis.
j Sondylolisthesis at L3.
k On the basis of history.
l Short nasal spine, small nose, and anteverted nares.
analysis and RNA analysis. Informed consent was ob-
tained from all the subjects.
Mutation Analysis
Genomic DNA was isolated from EDTA-anticoagu-
lated blood. All 66 exons and the flanking sequences of
the COL11A2 gene were amplified by PCR to obtain
products of 182–441 bp (Vuoristo et al. 1995; Pihla-
jamaa et al. 1998). The PCR reactions were done in a
volume of 30 ml that contained 100–150 ng genomic
DNA, 5–10 pmol of the PCR primers, 1.5 mMofMgCl2,
0.2 mM of dNTPs, and 1 U of AmpliTaq Gold DNA
polymerase (Perkin-Elmer). The thermocycling condi-
tions were an initial denaturation at 95C for 10 min
followed by 33 cycles at 95C for 30 s, 60C for 30 s,
and 72C for 40 s, and a final extension at 72C for 10
min. To generate heteroduplexes for conformation-sen-
sitive gel electrophoresis (CSGE), the samples were de-
natured at 95C for 5 min and annealed at 68C for 30
min. To screen individuals that could be homozygous
for mutations, the patients’ PCR products were mixed
with an equal amount of PCR products from the control
subjects before heteroduplexing. The PCR productswere
first analyzed for quality and quantity on agarose gel,
after which 50–100 ng of heteroduplexed sample was
analyzed on CSGE as described earlier (Ganguly et al.
1993; Ko¨rkko¨ et al. 1998).
Sequencing
PCR products that showed previously unidentified
patterns in CSGE were sequenced with an ABI prism
377 sequenator and dRhodamine Terminator Cycle Se-
quencing Ready Reaction Kit (Perkin-Elmer) to reveal
the underlying sequence variations. The sequence vari-
ations were confirmed by using both forward and reverse
primers. In most cases PCR primers were used for
sequencing.
RNA Analysis
Total RNA was extracted from Epstein-Barr vi-
rus–transformed lymphoblasts (Rapid RNA isolation
Kit, Qiagen). The first strand cDNA was synthesized
with a Superscript Preamplification System (Gibco BRL)
by using random hexameres, and PCR amplification of
the cDNA was done by using primers corresponding to
exons 21 (5′-GGA CCT CGA GGT CTC CTT GG) and
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Table 3
COL11A2-Gene Mutations in Families with OSMED
SUBJECT(S)
MUTATIONa
LOCATION PREDICTED CONSEQUENCE(S)Homozygous Heterozygous
A:II3 and A:II4 732delCb Exon 5 Frameshift stop in E6
B:II3 and B:II4 2492CrAb Exon 33 S345X
C:II1 2406–2409del, 2405–2410ins9bp Exon 31 Frameshift stop in exon 32
D:II1 4821–4843delb Exon 64 Frameshift stop in exon 64
E:II2 1636CrTc Exon 17 R60X
IVS22–2ArGd IVS22 In-frame deletion of exon 23 (54 bp)
F:II1 3032–3033insC Exon 41 Frameshift stop in exon 43
4750GrT Exon 63 G1098X
G:II1 and G:II2 3991CrTd Exon 55 R845X
IVS535GrAc IVS53 Frameshift stop in 56
a A is from the ATG of the initiator methionine codon and is designated as nucleotide “1.”
b Inherited from both the father and the mother.
c Inherited from the mother.
d Inherited from the father.
26 (5′-ACCTTCCTTCCCTGGGTGACC), and exons
50 (5′-AGT CAG GAT CTC CAG GGA TCC) and 56
(5′-CCT ATA GCG CCA GGA TCT CC) of the a2(XI)
cDNA (Vuoristo et al. 1995). Nested primers from exons
22 (5′-GGC GTC CGA GGC ATG GAT GGT C) and
25 (5′-GTC CGT CTG AGC CAG GCA TG), and exons
51 (5′-GGG GCA GCC AGG AGA GCC AG) and 55
(5′-CCT CGG AAC CAG GCG AGC CA) were used for
a second PCR amplification. The PCR reactions were
done in a volume of 100 ml by using 2 ml of PCR tem-
plate, 34 pmol of each primer, and 5 U of AmpliTaq
Gold DNA polymerase. PCR conditions included one
cycle at 95C for 10 min and 33 cycles at 95C for 40
s, 60C for 40 s, 72C for 45 s followed by one cycle at
72C for 10 min. The PCR products were analyzed on
2% agarose gel, and the products of the second PCR
amplification were sequenced.
Results
Clinical Data
Family A consisted of consanguineous parents of
Turkish descent and four children (fig. 1). The first and
second pregnancies had ended in spontaneous abortion,
after which two healthy children and two affected ones
had been born. The clinical data on the patients (table
1) A:II3 and A:II4 have been published elsewhere (Miny
and Lenz 1985). Clinical findings of the parents are listed
in table 2.
Family B (fig. 1) originated from Morocco and con-
sisted of consanguineous parents (table 2), three affected
children and one unaffected child. The third child, B:II3
had normal body length (48 cm) at birth, but short limbs
with enlarged joints and stiff interphalangeal joints. The
radiological features included vertebral coronal clefts,
square iliac wings and a thick ischium, large metaphyses
of the long bones and enlarged epiphyses of the elbows
and knees. At age 7 years she was of nearly normal
height (115 cm, 1 SD), but disproportionate, and her
palate was extremely narrow, with a double row of teeth
(table 1). Eye examination revealed slight myopia. The
clinical and radiological features of the fourth child, B:
II4, were similar to those of her sister, B:II3, but her
vision was normal. The family’s second child was still-
born with neonatal rhizomelic dwarfism. In view of the
radiographic findings regarding the skeleton, she was
considered afterwards to have hadOSMED (not shown).
Patient C:II1 was born to healthy consanguineous
Turkish parents (family C; see fig. 1 and table 2). The
patient was noted to have a flat face with posterior me-
dial palatal clefting and micrognathia immediately after
birth, there was insufficient ventilation and the neonate
had to be intubated and ventilated for 24 h and given
continuous positive airway pressure for another 5 d.
Respiratory symptoms were prominent for the first 2
years, with a mixed inspiratory/expiratory obstruction
pattern precipitated by minor viral airway infections or
by physical exercise. The phenotypic features were sim-
ilar to those of the other patients (table 1). Kniest dys-
plasia was considered in the first year of life, but the
radiological findings were entirely consistent with OS-
MED. The trachea was unusually narrow during the first
2 years but grew to low normal dimensions later. The
boy is of normal intelligence and socially pleasant and
well integrated, albeit handicapped by the hypoacusis
and speech defect. He has a younger brother who is
clinically unremarkable.
The patient D:II2 (fig. 1) was the second child of
healthy Dutch parents (table 2). Genealogical analysis
of the parents’ ancestry going back five generations re-
vealed no consanguinity. The patient was born at term
after a normal pregnancy. Length at birth was 54 cm.
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Figure 1 Pedigrees of families with OSMED
Table 4
Comparison of Clinical Findings in the Cases of OSMED
CHARACTERISTIC
FREQUENCY IN
Present
Study
van Steensel
et al. (1997)
Other Reported
Cases of OSMEDa
Disproportionately short limbs 10/10 2/3 6/6
Enlarged joints 10/10 3/3 6/6
Vertebral body anomalies 10/10 3/3 6/6
Small chin 7/10 0/3 6/6
Cleft palate/bifid uvula 10/10 0/3 6/6
Midfacial hypoplasia 10/10 3/3 6/6
Sensorineural hearing loss 10/10 3/3 6/6
Prominent supraorbital ridges 0/10 2/3 Unknown
Limited flexion of metacarpophalangeal/interphalangeal joints 7/8 3/3 3/6
a Reported by Insley and Astley (1974), Giedion et al. (1982) (case a), Salinas et al. (1986), and Johnston et
al. (1987).
The phenotypical findings were consistent with OSMED
(table 1). Radiographs of the skeleton at age 5 mo
showed markedly short extremities with pronounced
metaphyseal flaring of the long bones, especially the fem-
ora, and the vertebral bodies seemed almost fragmented
(not shown). The skull showed no apparent abnormal-
ities (not shown). Radiographs at age 16 mo revealed
broad metaphyses with metaphyseal flaring of the long
bones (fig. 2, left and middle) and disproportionately
large epiphyses in the hips and knees and mild platys-
pondyly with irregularities in the endplates of the ver-
tebrae (fig. 2, right). The phalangeal epiphyses were also
large. Ophthalmological assessment revealed no abnor-
malities. At the time of this study, the patient (age 7
years) had normal intelligence and normal height but
still had disproportionately short limbs with large joints
and had pain in her hips, knees, and ankles after minor
exercise. She has a healthy 9-year-old sister (D:II1).
Patient E:II2 was the second of three children to non-
consanguineous parents (fig. 1; table 2). The family orig-
inated from the Netherlands. A clinical description of
the patient has been published earlier (table 1; Ka¨a¨ri-
a¨inen et al. 1993; patient 3). In addition to clinical fea-
tures described in table 1, patient E:II2 had mild to mod-
erate flexion contractures in several joints, extensive
osteoporosis (especially in spine), a brachycephalic skull,
and a prominent mandible.
Patient F:II1 was the only child of nonconsanguineous
parents of Finnish descent (fig. 1; table 2). The clinical
description of the patient has been published earlier
(Ka¨a¨ria¨inen et al. 1993; patient 2). The main clinical
features are described in table 1.
Patients G:II1 (see fig. 3) and G:II2 were male twins
of indeterminate zygosity born at 34 wk gestation to
nonconsanguineous parents of Northern European de-
scent (fig. 1; table 2). Respiratory distress was apparent
in patient G:II1 from birth. Airway obstruction second-
ary to Robin sequence together with bronchoscopically
confirmed laryngomalasia necessitated intubation soon
after birth. A tracheostomy was done at age 3 wk. Air-
way obstruction in G:II2 was initially less severe and
tracheostomy was not needed until age 3 mo. Decan-
nulation was accomplished at age 31 mo, in both cases.
The phenotypic features of the twins were virtually iden-
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Figure 2 Radiographs of femur (left), humerus (middle), and spinal column (right) of patient DII:2 at age 16 mo
tical as described in table 1. Radiograph of lateral spine
of G:II1 at age 3 mo showed mild platyspondyly and
coronal clefting (fig. 4, left). Radiograph of GII:2 at 9
age mo showed shortening of the long bones and quite
marked metaphyseal flaring (fig. 4, middle). In the ra-
diograph of pelvis and hips of G:II1 at age 2 years 5 mo
were seen short and broad basilar portions of the ilia
and relatively horizontal acetabular roofs, as well as
coxa vara (fig. 4, right). In addition, the clinical features
included a prominent occiput, and mild parietal and
frontal bossing and mild generalized brachydactyly.
Mutation Analysis
All 66 exons and the flanking sequences of the
COL11A2 gene were amplified from genomic DNA of
one affected member of each family. The amplified prod-
ucts were analyzed on CSGE together with the control
samples. Also, equal amounts of the PCR products of
the affected individuals were mixed with the control
samples for heteroduplexing and analysis on CSGE. The
analysis identified several unique CSGE patterns (data
not shown). The exons with the unique patterns were
then analyzed for all available family members. Sequenc-
ing indicated that all the patients had COL11A2 mu-
tations (fig. 5 and table 3). The affected individuals in
all the consanguineous families (A–C) and in one non-
consanguineous family (D) were homozygous for mu-
tations whereas those in the remaining nonconsanguin-
eous families (E–G) were compound heterozygous for
mutations. All the families had different mutations that
either generated premature translation termination co-
dons or altered the splicing consensus sequences (table
3). Analysis of samples from all the available parents
(12/14) indicated that the mutations were inherited
rather than sporadic.
RNA Analysis
To show the consequences of the intronic mutations
(IVS22-2ArG and IVS535GrA) in patients E:II2, G:
II1, and G:II2, total RNAwas extracted fromEBV-trans-
formed lymphoblasts obtained from mother E:I2,
mother G:I2 (fig. 1 and table 2), and a control subject.
RNA samples were reverse transcribed and PCR prod-
ucts generated from exon 21 to exon 26 (E:I2 and con-
trol) and from exon 50 to exon 56 (G:I2 and control).
The second PCR amplification was done by using nested
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Figure 3 Patient G:II1 at age 18 mo
primers. Analysis of the PCR product of E:I2 on agarose
gel revealed two bands, of ∼150 bp and ∼200 bp, with
an equal intensity, but only one band, of ∼200 bp, in
the control sample (data not shown). Sequencing of the
shorter product indicated skipping of exon 23, and thus
an in-frame deletion of 54 nucleotides (data not shown).
Analysis of the PCR products on agarose gel showed no
difference between the control and G:I2. Sequencing re-
vealed that the G:I2s mutant allele used a cryptic splice
site in exon 53, eliminating 17 bp at the end of the exon.
This frameshift results in a premature translation ter-
mination codon in exon 56.
Discussion
Analysis of seven families with OSMED for mutations
in the COL11A2 gene showed each to have different
COL11A2mutations. The individuals were homozygous
for mutations in all three families of consanguineous
parents and in one family with nonrelated parents, and
compound heterozygous in the other three families with
nonrelated parents. Altogether 10 mutations were iden-
tified, nine of which led to the generation of a premature
translation termination codon because of either deletions
or single base substitutions, whereas one altered a con-
sensus sequence for splicing. Thus the data predicts that
the affected members of six of the seven families com-
pletely lack a2(XI) chains or produce truncated a2(XI)
chains, which are unlikely to be incorporated into type
XI collagen molecules.
The clinical findings for all the patients described here
or described earlier have been very similar (tables 1 and
4). The three siblings of the family that were reported
to be homozygous for Gly175rArg substitution (van
Steensel et al. 1997) had a slightly different phenotype
from the other patients, as none of the three siblings had
the small chin, cleft palate, or bifid uvula typically seen
in the patients analyzed here and in the OSMED cases
reported earlier (table 4). In addition, the three siblings
were reported to have severe osteoarthritis, which has
not been reported in the other OSMED cases. The phe-
notypical variation may reflect the fact that haploinsuf-
ficiency and mutations with a dominant negative effect
on collagens generally result in different phenotypes or
degrees of severity (Kuivaniemi et al. 1997). It is also
well known that in addition to the type of a mutation,
the location of a mutation in collagens may modify the
phenotype or its severity (Spranger et al. 1994; Horton
1996; Kuivaniemi et al. 1997; Spranger 1998). This is
also supported by the finding here that the parents with
COL11A2 null-allele mutations, as well as the individ-
uals heterozygous for Gly175rArg substitution, had ap-
parently normal phenotype (van Steensel et al. 1997).
However, one parent (E:I2) with a COL11A2 splicing
mutation had a mild phenotype consisting mainly of
dysmorphic facial features resembling those of the pa-
Figure 4 Left, Radiograph of spine of patient G:II1 at age 3 mo. Middle, Radiograph of left arm of patient G:II2 at age 9 mo. Right, Radiograph of anteroposterior pelvis and hips of patient
G:II1 at age 2 years 5 mo.
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Figure 5 Sequencing of PCR products from a control subject
(top) and individual C:II1 (bottom), for exon 31 of the COL11A2
gene. The underlined sequence in the top panel indicates the deletion,
whereas the underlined sequence in the bottom panel indicates the
insertion.
tients with a small in-frame deletion or a splicing mu-
tation in COL11A2 having phenotype of nonocular
Stickler syndrome (Vikkula et al. 1995; Sirko-Osadsa et
al. 1998).
The finding here that the absence of the a2 (XI) chains
produces a nonlethal phenotype was surprising because
the lack of the other type XI collagen a chains, a1 (XI)
or a1 (II) , result in a lethal phenotype in mice (Li et al.
1995a; Li et al. 1995b). This could be explained by other
a chains partially compensating for the lack of the
a2(XI) chains. In the bovine vitreous body, the a2(V)
chain normally substitutes for the a2(XI) chain to form
a type V/XI hybrid molecule. Further support for the
other a chains partially compensating for the a2(XI)
chain’s absence derives from transgenic mice with a tar-
geted disruption of the Col11a2 gene (S.-W. Li, P. Van-
denberg, M. Takanosu, M. Arita, Y. Bao, Z-X Ren, R.
Mayne, and D. J. Prockop, personal communication).
The phenotype of the mice homozygous for Col11a2
null mutation is similar to that of the patients with OS-
MED. Interestingly, the a1(XI) and a1V) chains are re-
covered after pepsin digestion of the rib cartilage of these
mice, suggesting that a1(XI) or a1(V) chains form triple-
helical molecules in the absence of the a2(XI) chains.
Our data suggests that complete absence of a2(XI)
collagen chains is not lethal, but results in a character-
istic phenotype, which includes facial features, skeletal
dyplasia and disproportion, and severe hearing loss. OS-
MED is an autosomal recessive disorder with a recur-
rence risk of 25%. This contrasts with the more common
autosomal dominant collagen disorders, where it is as-
sumed that de novo mutations account for unaffected
parents having an affected child, and therefore the re-
currence risk is low. Consequently, early recognition of
the OSMED phenotype is important for accurate coun-
seling. Advances in molecular diagnosis now provide an
option for prenatal diagnosis in the “at-risk”
pregnancies.
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